World's Best Scientists 2026 revealed!
Award Badge
Rising Stars
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Rising Stars 52 269 269 46 46 150 10427
Molecular Biology 53 2379 2142 1176 1047 333 11994

Henry W. Long publications per year

The chart shows the history of publications by Henry W. Long between 1998 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Henry W. Long published across 28 years, from 1998 to 2025, averaging 22 papers a year. Output peaked at 265 publications in 2023. 185 of the 616 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 1998 to 2025. Vertical axis: number of publications, 0 to 265. Peak 265 publications in 2023. 1998: 2 publications 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 0 publications 2003: 0 publications 2004: 0 publications 2005: 0 publications 2006: 0 publications 2007: 0 publications 2008: 0 publications 2009: 0 publications 2010: 0 publications 2011: 0 publications 2012: 1 publication 2013: 3 publications 2014: 3 publications 2015: 8 publications 2016: 15 publications 2017: 9 publications 2018: 15 publications 2019: 11 publications 2020: 42 publications 2021: 30 publications 2022: 27 publications 2023: 265 publications 2024: 114 publications 2025: 71 publications
1998 2025

616 publications in total across all disciplines

View publications per year as a table
Henry W. Long: publications per year, 1998 to 2025
Year Publications
1998 2
1999 0
2000 0
2001 0
2002 0
2003 0
2004 0
2005 0
2006 0
2007 0
2008 0
2009 0
2010 0
2011 0
2012 1
2013 3
2014 3
2015 8
2016 15
2017 9
2018 15
2019 11
2020 42
2021 30
2022 27
2023 265
2024 114
2025 71
Total 616
Download as CSV

Henry W. Long publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Henry W. Long sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 327–336 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 333 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42 333
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Henry W. Long D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Henry W. Long sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106 53
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Research.com Recognitions

  • 2025 - Research.com Rising Stars Award

Overview

Henry W. Long is affiliated with Harvard University in the United States, where their work primarily spans the disciplines of Biochemistry, Genetics, and Molecular Biology, with extensive contributions to Medicine. Their research focuses on several subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Immunology.

Long's main topics of study cover a range of areas related to cancer and genetics. These include Epigenetics and DNA Methylation, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Genomics and Chromatin Dynamics, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Lung Cancer Research Studies.

Their recent notable publications include:

  • Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway, 2020, Cancer Cell
  • Prostate cancer reactivates developmental epigenomic programs during metastatic progression, 2020, Nature Genetics
  • Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade, 2021, Cancer Discovery
  • EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer, 2021, Nature Cancer
  • Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer, 2020, Cancer Research

Frequent co-authors who have collaborated extensively with Long include:

  • Paloma Cejas
  • Xintao Qiu
  • Myles Brown
  • Yingtian Xie
  • Matthew L. Freedman

Long's work has been regularly published in venues such as Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Cancer Cell, and Nature Genetics. Their publication record shows a considerable focus on high-impact journals related to cancer and molecular biology research.

Best Publications

  • Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

    Sheng Yu Ku;Spencer Rosario;Yanqing Wang;Ping Mu

  • A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

    Deng Pan;Aya Kobayashi;Aya Kobayashi;Peng Jiang;Lucas Ferrari de Andrade

  • Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

    Shaokun Shu;Charles Y. Lin;Housheng Hansen He;Robert M. Witwicki

  • The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

    Mark M Pomerantz;Fugen Li;David Y Takeda;David Y Takeda;Romina Lenci

  • HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia

    Matthew D. Galbraith;Mary A. Allen;Claire L. Bensard;Xiaoxing Wang;Xiaoxing Wang

  • Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

    Kari J. Kurppa;Yao Liu;Ciric To;Tinghu Zhang

  • The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    Elizabeth C. Townsend;Mark A. Murakami;Alexandra Christodoulou;Amanda L. Christie

  • A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer

    David Y. Takeda;David Y. Takeda;Sándor Spisák;Ji Heui Seo;Connor Bell

  • Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity

    Tae-Hee Kim;Fugen Li;Isabel Ferreiro-Neira;Isabel Ferreiro-Neira;Li-Lun Ho;Li-Lun Ho

  • Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations

    Rinath Jeselsohn;Rinath Jeselsohn;Johann S. Bergholz;Matthew Pun;MacIntosh Cornwell

  • Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification

    Housheng Hansen He;Clifford A. Meyer;Sheng'En Shawn Hu;Sheng'En Shawn Hu;Mei Wei Chen

  • Prostate cancer reactivates developmental epigenomic programs during metastatic progression

    Mark M. Pomerantz;Xintao Qiu;Yanyun Zhu;David Y. Takeda;David Y. Takeda

  • VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis

    MacIntosh I. Cornwell;Mahesh Vangala;Len Taing;Zachary Herbert

  • Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.

    Shengqing Stan Gu;Wubing Zhang;Wubing Zhang;Xiaoqing Wang;Peng Jiang

  • EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.

    Katherine L. Morel;Anjali V. Sheahan;Deborah L. Burkhart;Sylvan C. Baca

  • Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.

    Neel Shah;Ping Wang;John Wongvipat;Wouter R Karthaus

  • ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

    Laura Cato;Jonas de Tribolet-Hardy;Jonas de Tribolet-Hardy;Irene Lee;Jaice T. Rottenberg

  • Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.

    Paloma Cejas;Yotam Drier;Yotam Drier;Yotam Drier;Koen M.A. Dreijerink;Lodewijk A.A. Brosens

  • Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

    Shaokun Shu;Hua-Jun Wu;Jennifer Y. Ge;Jennifer Y. Ge;Rhamy Zeid

  • Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

    Shaokun Shu;Charles Y. Lin;Housheng Hansen He;Robert M. Witwicki

Frequent Co-Authors

Myles Brown
Myles Brown Harvard University
Matthew L. Freedman
Matthew L. Freedman Harvard University
X. Shirley Liu
X. Shirley Liu Harvard University
Clifford A. Meyer
Clifford A. Meyer Harvard University
William C. Hahn
William C. Hahn Dana-Farber Cancer Institute
Kornelia Polyak
Kornelia Polyak Harvard University
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Ramesh A. Shivdasani
Ramesh A. Shivdasani Harvard University
Massimo Loda
Massimo Loda Cornell University
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your career options beyond Molecular Biology, there are a wide range of online healthcare degrees and pathways to consider. Many professionals choose to transition into advanced nursing or allied health careers, as these fields offer strong job prospects and flexible educational options.

For those curious about advancing in nursing, understanding how long to become nurse practitioner is an important consideration. Accelerated programs can help you enter the workforce quickly. For registered nurses, the fastest rn to bsn program online allows you to upgrade your credentials in as little as six months, opening doors to leadership and research roles.

If you’re a nurse looking to move into advanced practice, rn to np programs online offer streamlined pathways to become a nurse practitioner for those with varying educational backgrounds. Even non-nurses can consider transition programs such as online msn programs for non nurses to enter advanced nursing roles.

Whether your interest lies in laboratory science, patient care, or research, there are many flexible online pathways to meet your career goals and help shape the future of healthcare.

Best Scientists Citing Henry W. Long

Trending Scientists

Recently Published Articles